Physician profile
Subhash Banerjee
NPI 1407892458
$141,631.62
in general payments reported to CMS, 2019-2025
36 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $8,412 · 2021: $4,266 · 2022: $11K · 2023: $67K · 2024: $19K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,760 · Food and Beverage: $9,614 · Travel and Lodging: $21.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $60,549.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,324.97 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,760.00 |
| Food and Beverage | $9,613.81 |
| Travel and Lodging | $21.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $58,947.85 | 2019-2025 | Esprit, Thoratec Heartmate 3 Lvas Implant Kit, Xience Skypoint |
| Astrazeneca Pharmaceuticals LP | $19,377.99 | 2019-2024 | |
| Kaneka Medical America LLC | $17,095.04 | 2019-2025 | Apheresis Machine |
| Biotronik INC. | $12,637.24 | 2020-2025 | Orsiro Mission |
| Ge Healthcare | $10,669.78 | 2019-2025 | |
| Boston Scientific Corporation | $5,302.51 | 2019-2025 | Ekosonic, Avvigo Guidance System, General - Structural Heart |
| Cardinal Health 200 LLC | $2,609.27 | 2019-2020 | |
| Medtronic, INC. | $2,292.52 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Tri-Ad |
| Cordis US Corp. | $2,200.90 | 2021-2023 | Brite Tip Radianz, Selution Slrpta |
| Terumo Medical Corporation | $1,889.26 | 2020-2025 | Metacross Otw, Glidewire, Heartrail |
| Edwards Lifesciences Corporation | $1,877.63 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Teleflex LLC | $1,373.83 | 2023-2025 | Manta, Guideliner, Trapliner |
| Amgen INC. | $1,330.05 | 2023-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $1,176.25 | 2019-2020 | |
| Abiomed | $677.65 | 2019-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $306.17 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Spectrawave, INC | $297.22 | 2025 | Starlight Imaging Catheter, Hypervue Imaging System |
| Limflow INC. | $296.88 | 2023 | Limflow System |
| Esperion Therapeutics, INC. | $263.56 | 2021-2023 | Nexletol |
| W. L. Gore & Associates, INC. | $236.65 | 2019-2023 | Gore Viabahn Endoprosthesis With Heparin |
| Penumbra, INC. | $149.75 | 2020 | |
| Novartis Pharmaceuticals Corporation | $137.82 | 2022-2024 | |
| Siemens Medical Solutions USA, INC. | $100.48 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $97.27 | 2025 | Evkeeza |
| Heartflow, INC. | $56.27 | 2023-2024 | Ffrct |
| Cardiva Medical, INC. | $55.60 | 2024 | Savvywire |
| Novo Nordisk INC | $48.73 | 2024-2025 | Ozempic, Rybelsus |
| Tactile Systems Technology INC | $35.69 | 2023 | Flexitouch Plus, Entre Plus |
| Convatec INC. | $28.30 | 2023 | |
| Cvrx, INC. | $25.98 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.29 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.19 | 2023 | Lifevest |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subhash Banerjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.